The role of P2Y receptors in the control of blood pressure

Drug News and Perspectives

Volumn 15, Issue 10, 2002, Pages 640-646

  Van der Giet, Markus ^a   Giebing, Günter ^b   Tölle, Markus ^b   Schmidt, Sven ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; NUCLEOTIDE; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y13 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; RECEPTOR SUBTYPE; RHO KINASE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL SURFACE; ENDOTHELIUM CELL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0036975159     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.10.740237     Document Type: Article

References (88)

1. Burnstock, G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 1997, 36: 1127-39.
2. Abbracchio, M.P. and Burnstock, G. Purinoceptors: Are there families of P2X and P2Y purinoceptors? Pharmacol Ther 1994, 64: 445-75.
3. von Kugelgen, I. and Wetter, A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 2000, 362: 310-23.
4. Kennedy, C. The discovery and development of P2 receptor subtypes. J Auton Nerv Syst 2000, 81: 158-63.
5. Kunapuli, S.P. and Daniel, J.L. P2 receptor subtypes in the cardiovascular system. Biochem J 1998, 336: 513-23.
6. Boarder, M.R. and Hourani, S.M. The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors. Trends Pharmacol Sci 1998, 19: 99-107.
7. Barnard, E.A., Simon, J. and Webb, T.E. Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms. Mol Neurobiol 1997, 15: 103-29.
8. Stone, T.W. Receptors for adenosine and adenine nucleotides. Gen Pharmacol 1991, 22: 25-31.
9. Ralevic, V. and Burnstock, G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413-92.
10. Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J.M., Morelli, A., Torboli, M., Bolognesi, G. and Baricordi, O.R. Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood 2001, 97: 587-600.
11. Burnstock, G. and Williams, M. P2 purinergic receptors: Modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 2000, 295: 862-9.
12. North, R.A. and Surprenant, A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 2000, 40: 563-80.
13. Luo, J., Jankowski, J., Tepel, M., von Der Giet, M., Zidek, W. and Schluter, H. Identification of diadenosine hexaphosphate in human erythrocytes. Hypertension 1999, 34: 872-5.
14. Luo, J., Jankowski, J., Knobloch, M., Van der Giet, M., Gardanis, K., Russ, T., Vahlensieck, U., Neumann, J., Schmitz, W., Tepel, M., Deng, M.C., Zidek, W. and Schluter, H. Identification and characterization of diadenosine 5′,5‴-P1,P2-diphosphate and diadenosine 5′,5‴-P1,P-3triphosphate in human myocardial tissue. FASEB J 1999, 13: 695-705.
15. Jankowski, J., Hagemann, J., Yoon, M.S., van der Giet, M., Stephan, N., Zidek, W., Schluter, H. and Tepel, M. Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int 2001, 59: 1134-41.
16. Jankowski, J., Tepel, M., van der Giet, M., Tente, I.M., Henning, L., Junker, R., Zidek, W. and Schluter, H. Identification and characterization of P(1), P(7)-Di(adenosine-5′)heptaphosphate from human platelets. J Biol Chem 1999, 274: 23926-31.
17. Schluter, H., Grobeta, I., Bachmann, J., Kaufmann, R., van der Giet, M., Tepel, M., Nofer, J.R., Assmann, G., Karas, M., Jankowski, J. and Zidek, W. Adenosine(5′) oligophospho-(5′) guanosines and guanosine(5′) oligophospho-(5′) guanosines in human platelets. J Clin Invest 1998, 101: 682-8.
18. Schluter, H., Offers, E., Bruggemann, G., van der Giet, M., Tepel, M., Nordhoff, E., Karas, M., Spieker, C., Witzel, H. and Zidek, W. Diadenosine phosphates and the physiological control of blood pressure. Nature 1994, 367: 186-8.
19. Jovanovic, A., Jovanovic, S., Mays, D.C., Lipsky, J.J. and Terzic, A. Diadenosine 5′,5″-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett 1998, 423: 314-8.
20. Jankowski, J., Yoon, M.S., Stephan, N., Zidek, W. and Schluter, H. Vasoactive diadenosine polyphosphates in human placenta: Possible candidates in the pathophysiology of pre-eclampsia? J Hypertens 2001, 19: 567-73.
21. van der Giet, M., Schmidt, S., Tolle, M., Jankowski, J., Schluter, H., Zidek, W. and Tepel, M. Effects of dinucleoside polyphosphates on regulation of coronary vascular tone. Eur J Pharmacol 2002, 448: 207-13.
22. van der Giet, M., Westhoff, T., Cinkilic, O., Jankowski, J., Schluter, H., Zidek, W. and Tepel, M. The critical role of adenosine and guanosine in the affinity of dinucleoside polyphosphates to P(2X)-receptors in the isolated perfused rat kidney. Br J Pharmacol 2001, 132: 467-74.
23. van der Giet, M., Cinkilic, O., Jankowski, J., Tepel, M., Zidek, W. and Schluter, H. Evidence for two differeut P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney. Br J Pharmacol 1999, 127: 1463-9.
24. van der Giet, M., Jankowski, J., Schluter, H., Zidek, W. and Tepel, M. Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors. J Hypertens 1998, 16: 1939-43.
25. van der Giet, M., Khattab, M., Borgel, J., Schluter, H. and Zidek, W. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 1997, 120: 1453-60.
26. Vahlensieck, U., Boknik, P., Gombosova, I., Huke, S., Knapp, J., Linck, B., Luss, H., Muller, H.L., Neumann, J., Deng, M.C., Scheld, H.H., Jankowski, H., Schluter, H., Zidek, W., Zimmermann, N. and Schmitz, W. Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 1999, 288: 805-13.
27. Steinmetz, M., Schlatter, E., Boudier, H.A., Rahn, K.H. and De Mey, J.G. Diadenosine polyphosphates cause contraction and relaxation in isotaled rat resistance arteries. J Pharmacol Exp Ther 2000, 294: 1175-81.
28. Steinmetz, M., Bierer, S., Hollah, P., Rahn, K.H. and Schlatter, E. Heterogenous vascular effects of AP5A in different rat resistance arteries are due to heterogenous distribution of P2X and P2Y(1) purinoceptors. J Pharmacol Exp Ther 2000. 294: 1182-7.
29. Floresc N.A., Stavrouc B.M. and Sheridanc D.J. The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc Res 1999, 42: 15-26.
30. Kisselev, L.L., Justesen, J., Wolfson, A.D. and Frolova, L.Y. Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules? FEBS Lett 1998, 427: 157-63.
31. Leon, C., Vial, C., Cazenave, J.P. and Gachet, C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene 1996, 171: 295-7.
32. Jin, J. and Kunapuli, S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998, 95: 8070-4.
33. Fabre, J.E., Nguyen, M., Latour, A., Keifer, J.A., Audoly, L.P., Coffman, T.M. and Koller, B.H. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999, 5: 1199-202.
34. Cressman, V.L., Lazarowski, E., Homolya, L., Boucher, R.C., Koller, B.H. and Grubb, B.R. Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(-) transport. J Biol Chem 1999, 274: 26461-8.
35. Parr, C.E., Sullivan, D.M., Paradiso, A.M., Lazarowski, E.R., Burch, L.H., Olsen, J.C., Erb, L., Weisman, G.A., Boucher, R.C. and Turner, J.T. Cloning and expression of a human P2U nucleotide receptor a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 1994, 91: 13067.
36. Janssens, R., Paindavoine, P., Parmentier, M. and Boeynaems, J.M. Human P2Y2 receptor polymorphism: Identification and pharmacological characterization of two allelic variants. Br J Pharmacol 1999, 127: 709-16.
37. Webb, T.E., Simon, J., Krishek, B.J., Bateson, A.N., Smart, T.G., King, B.F., Burnstock, G. and Barnard, E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 1993, 324: 219-25.
38. Deng, G., Matute, C., Kumar, C.K., Fogarty, D.J. and Miledi, R. Cloning and expression of a P2y purinoceptor from the adult bovine corpus callosum. Neurobiol Dis 1998, 5: 259-70.
39. Akbar, G.K., Dasari, V.R., Webb, T.E., Ayyanathan, K., Pillarisetti, K., Sandhu, A.K., Athwal, R.S., Daniel, J.L., Ashby, B., Barnard, E.A. and Kunapuli, S.P. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J Biol Chem 1996, 271: 18363-7.
40. Janssens, R., Communi, D., Pirotton, S., Samson, M., Parmentier, M. and Boeynaems, J.M. Cloning and tissue distribution of the human P2Y1 receptor. Biochem Biophys Res Commun 1996, 221: 588-93.
41. Palmer, R.K., Boyer, J.L., Schachter, J.B., Nicholas, R.A. and Harden, T.K. Agonist action of adenosine triphosphates at the hmnan P2Y1 receptor. Mol Pharmacol 1998, 54: 1118-23.
42. O'Grady, S.M., Elmquist, E., Filtz, T.M. Nicholas, R.A. and Harden, T.K. A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y1 receptor expression in Xenopus oocytes. J Biol Chem 1996, 271: 29080-7.
43. Moro, S., Guo, D., Camaioni, E., Boyer, J.L., Harden, T.K. and Jacobson, K.A. Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem 1998, 41: 1456-66.
44. Schachter, J.B., Li, Q., Boyer, J.L., Nicholas, R.A. and Harden, T.K. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol 1996, 118: 167-73.
45. Sauzeau, V., Le Jeune, H., Cario-Toumaniantz, C., Vaillant, N., Gadeau, A.P., Desgranges, C., Scalbert, E., Chardin, P., Pacaud, P. and Loirand, G. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 2000, 278: H1751-61.
46. Leon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J.P. and Gachet, C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997, 403: 26-30.
47. Erlinge, D., Hou, M., Webb, T.E., Barnard, E.A. and Moller, S. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 1998, 248: 864-70.
48. Hansmann, G., Ihling, C., Pieske, B. and Bultmann, R. Nucleotide-evoked relaxation of human coronary artery. Eur J Pharmacol 1998, 359: 59-67.
49. Leon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J.P. and Gachet, C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999, 104: 1731-7.
50. Neary, J.T. and Zhu, Q. Signaling by ATP receptors in astrocytes. Neuroreport 1994, 5: 1617-20.
51. Parr, C.E., Sullivan, D.M., Paradiso, A.M., Lazarowski, E.R., Burch, L.H., Olsen, J.C., Erb, L., Weisman, G.A., Boucher, R.C. and Turner, J.T. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 1994, 91: 13067.
52. Lazarowski, E.R., Watt, W.C., Stutts, M.J., Boucher, R.C. and Harden, T.K. Pharmacological selectivity of the cloned human P2U-purinoceptor: Potent activation by diadenosine tetraphosphate. Br J Pharmacol 1995, 116: 1619-27.
53. Nicholas, R.A., Watt, W.C., Lazarowski, E.R., Li, Q. and Harden, K. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol 1996, 50: 224-9.
54. Charlton, S.J., Brown, C.A., Weisman, G.A., Turner, J.T., Erb, L. and Boarder, M.R. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol 1996, 118: 704-10.
55. Boyer, J.L., Mohanram, A., Camaioni, E., Jacobson, K.A. and Harden, T.K. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br J Pharmacol 1998, 124: 1-3.
56. 2+ in human erythroleukemia cells. J Biol Chem 1997, 272: 10151-9.
57. Mosbacher, J., Maier, R., Fakler, B., Glatz, A., Crespo, J. and Bilbe, G. P2Y receptor subtypes differentially couple to inwardly-rectifying potassium channels. FEBS Lett 1998, 436: 104-10.
58. Filippov, A.K., Webb, T.E., Barnard, E.A. and Brown, D.A. P2Y2 nucleotide receptors expressed heterologously in sympathetic neurons inhibit both N-type Ca2+ and Mtype K+ currents. J Neurosci 1998, 18: 5170-9.
59. Filippov, A.K., Webb, T.E., Barnard, E.A. and Brown, D.A. Dual coupling of heterologously-expressed rat P2Y6 nucleotide receptors, to N-type Ca2+ and M-type K+ currents in rat sympathetic neurones. Br J Pharmacol 1999, 126: 1009-17.
60. Bowden, A., Patel, V., Brown, C. and Boarder, M.R. Evidence for requirement of tyrosine phosphorylation in endothelial P2Y-and P2U-purinoceptor stimulation of prostacyclin release. Br J Pharmacol 1995, 116: 2563-8.
61. Communi, D., Pirotton, S., Parmentier, M. and Boeynaems, J.M. Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem 1995, 270: 30849-52.
62. Nguyen, T., Erb, L., Weisman, G.A., Marchese, A., Heng, H.H., Garrad, R.C., George, S.R., Turner, J.T. and O'Dowd, B.F. Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J Biol Chem 1995, 270: 30845-8.
63. Communi, D., Motte, S., Boeynaems, J.M. and Pirotton, S. Pharmacological characterization of the human P2Y4 receptor. Eur J Pharmacol 1996, 317: 383-9.
64. Communi, D., Parmentier, M. and Boeynaems, J.M. Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun 1996, 222: 303-8.
65. Robaye, B., Boeynaems, J.M. and Communi, D. Slow desensitization of the human P2Y6 receptor. Eur J Pharmacol 1997, 329: 231-6.
66. Chang, K., Hanaoka, K., Kumada, M. and Takuwa, Y. Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J Biol Chem 1995, 270: 26152-8.
67. Hou, M., Harden, T.K., Kuhn, C.M., Baldetorp, B., Lazarowski, E., Pendergast, W., Moller, S., Edvinsson, L. and Erlinge, D. UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol 2002, 282: H784-92.
68. Communi, D., Govaerts, C., Parmentier, M. and Boeynaems, J.M. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 1997, 272: 31969-73.
69. Communi, D., Robaye, B. and Boeynaems, J.M. Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 1999, 128: 1199-206.
70. Hollopeter, G., Jantzen, H.M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.B., Nurden, P., Nurden, A., Julius, D. and Conley, P.B. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409: 202-7.
71. Simon, J., Filippov, A.K., Goransson, S., Wong, Y.H., Frelin, C., Michel, A.D., Brown, D.A. and Barnard, E.A. Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 2002, 277: 31390-400.
72. Zhang, F.L., Luo, L., Gustafson, E., Palmer, K., Qiao, X., Fan, X., Yang, S., Laz, T.M., Bayne, M. and Monsma, F., Jr. P2Y(13): Identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 2002, 301: 705-13.
73. Malmsjo, M., Hou, M., Harden, T.K., Pendergast, W., Pantev, E., Edvinsson, L. and Erlinge, D. Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5′-O-thiodiphosphate and uridine 5′-O-3-thiotriphosphate. J Pharmacol Exp Ther 2000, 293: 755-60.
74. Jin, J., Dasari, V.R., Sistare, F.D. and Kunapuli, S.P. Distribution of P2Y receptor subtypes on haematopoietic cells. Br J Pharmacol 1998, 123: 789-94.
75. Miyagi, Y., Kobayashi, S., Nishimura, J., Fukui, M. and Kanaide, H. Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation. Br J Pharmacol 1996, 118: 847-56.
76. Jankowski, J., Potthoff, W., van der Giet, M., Tepel, M., Zidek, W. and Schluter, H. High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets. Anal Biochem 1999, 269: 72-8.
77. Erlinge, D. Extracellular ATP: A growth factor for vascular smooth muscle cells. Gen Pharmacol 1998, 31: 1-8.
78. Harper, S., Webb, T.E., Charlton, S.J., Ng, L.L. and Boarder, M.R. Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br J Pharmacol 1998, 124: 703-10.
79. Hou, M., Moller, S., Edvinsson, L, and Erlinge, D. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 2000, 20: 2064-9.
80. Somlyo, A.P. and Somlyo, A.V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and nonmuscle myosin II. J Physiol 2000, 522: 177-85.
81. Satoh, S., Kreutz, R., Wilm, C., Ganten, D. and Pfitzer, G. Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells. J Clin Invest 1994, 94: 1397-403.
82. Kaibuchi, K., Kuroda, S. and Amano, M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999, 68: 459-86.
83. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. and Narumiya, S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389: 990-4.
84. Kandabashi, T, Shimokawa, H., Mukai, Y., Matoba, T., Kunihiro, I., Morikawa, K., Ito, M., Takahashi, S., Kaibuchi, K. and Takeshita, A. Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries. Arterioscler Thromb Vasc Biol 2002, 22: 243-8.
85. Masumoto, A., Hirooka, Y., Shimokawa, H., Hironaga, K., Setoguchi, S. and Takeshita, A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001, 38: 1307-10.
86. Ayyanathan, K., Webbs, T.E., Sandhu, A.K., Athwal, R.S., Barnard, E.A. and Kunapuli, S.P. Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun 1996, 218: 783-8.
87. Southey, M.C., Hammet, F., Hutchins, A.M., Paidhungat, M., Somers, G.R. and Venter, D.J. Molecular cloning and sequencing of a novel human P2 nucleotide receptor. Biochim Biophys Acta 1996, 1309: 77-80.
88. Maier, R., Glatz, A., Mosbacher, J. and Bilbe, G. Cloning of P2Y6 cDNAs and identification of a pseudogene: Comparison of P2Y receptor subtype expression in bone and brain tissues. Biochem Biophys Res Commun 1997, 237: 297-302.